Rodent versus human insulitis: Why the huge disconnect?

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 2, 2015, Pages 86-90

  In'T Veld, Peter ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

autoimmunity; insulitis; islets; type 1 diabetes

Indexed keywords

CD8+ T LYMPHOCYTE; DIABETIC PATIENT; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PANCREAS BIOPSY; PANCREAS ISLET; REVIEW; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; BLOOD; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS; PATHOPHYSIOLOGY; PROGNOSIS; SPECIES DIFFERENCE; TRANSLATIONAL RESEARCH;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; MICE, INBRED NOD; PANCREAS; PROGNOSIS; SPECIES SPECIFICITY; T-LYMPHOCYTES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84926299378     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000135     Document Type: Review

References (31)

1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014; 383:69-82.
2. Herold KC, Vignali DAA, Cooke A, Bluestone JA. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nature Rev 2013; 13:243-256.
3. Wallberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol 2013; 34:583-591.
4. Int Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011; 3:131-138.
5. Int Veld P. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol 2014; 36:569-579.
6. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-633.
7. Campbell-Thompson ML, Atkinson MA, Butler AE, et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia 2013; 56:2541-2543.
8. Asif S, Leete P, Nguyen V, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 2014; 63:3835-3845.
9. Krogvold L, Edwin B, Buanes T, et al. Pancreatic biopsies by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 2014; 57:841-843.
10. Nishida Y, Aida K, Kihara M, Kobayashi T. Antibody-validated proteins in inflamed islets of fulminant type 1 diabetes profiled by laser capture microdissection followed by mass spectrometry. PLOS one 2014; 9:e107664.
11. Hopfgarten J, Stenwall PA, Wilberg A, et al. Gene expression analysis of human islets in a subject at onset of type 1 diabetes. Acta Diabetol 2014; 51:199-204.
12. Bogdani M, Johnson PY, Potter-Perigo RS, et al. Hyaluronan and hyaluronanbinding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes 2014; 63:2727-2743.
13. Rowe P, Wasserfall C, Croker B, et al. Increased complement activation in human type 1 diabetes pancreata. Diabetes Care 2014; 36:3815-3817.
14. Korpos E, Kadri N, Kappelhoff R, et al. The peri-islet basement membrane, a barrier to infiltrating leucocytes in type 1 diabetes in mouse and human. Diabetes 2013; 62:531-542.
15. Chen J, Feigenbaum L, Aswashti P, et al. Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL15-Ra. Proc Natl Acad Sci USA 2013; 110:13534-13539.
16. Richardson SJ, Leete P, Bone AJ, et al. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 2013; 56:185-193.
17. Richardson SJ, Leete P, Dhayal S, et al. Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein VP1, in human pancreas. Diabetologia 2014; 57:392-401.
18. Schneider DA, von Herrath MG. Potential viral pathogenic mechanism in human type 1 diabetes. Diabetologia 2014; 57:2009-2018.
19. Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012; 209:51-60.
20. Rodriguez-Calvo T, Ekwall O, Amirian N, et al. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 2014; 63:3880-3890.
21. Skowera A, Ladell K, McLaren JE, et al. b-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes 2014. [Epub ahead of print]
22. Staeva TP, Chatenoud L, Insel R, Atkinson MA. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes 2013; 62:9-17.
23. Skog O, Korsgren S, Melhus A, Korsgren O. Revisiting the notion of type 1 diabetes being a T-cell mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes 2013; 20:118-123.
24. Donath MY, Hess C, Palmer E. What is the role of autoimmunity in type 1 diabetes? A clinical perspective. Diabetologia 2013; 57:653-655.
25. Ludviggson J. Is it time to challenge the established theories surrounding type 1 diabetes? Acta Paediatr 2014; 103:120-123.
26. Carrero JA, Calderon B, Towfic F, et al. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS One 2013; 8:e59701.
27. Willcox A, Richardson SJ, Bone AJ, et al. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2008; 155:173-181.
28. Int Veld P, Lievens D, De Grijse J, et al. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 2007; 56:2400-2404.
29. Daifotis AG, Koenig S, Chatenoud L, Herold KC. Anti-CD3 clinical trials in type 1 diabetes mellitus. Clin Immunol 2013; 149:268-278.
30. Pipeleers D, Ling Z. Pancreatic beta cells in insulin-dependent diabetes. Diab Metab Rev 1992; 8:209-227.
31. Pugliese A, Vendrame F, Reijonen H, et al. New insight on human type 1 diabetes biology: nPOD and nPOD transplantation. Curr Diab Rep 2014; 14:530.